{"id":"clm_5E921CD2E098","entity":"astrazeneca","predicate":"ceo","value":"Pascal Soriot","value_json":{"item":"Q7141722","rank":"preferred","check":{"on":"2026-11-09","url":"https://www.sec.gov/Archives/edgar/data/0000901832/000095010312004497/dp32579_6k.htm","pages":2,"quote":"Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012. Simon Lowth will remain as AstraZeneca’s Interim Chief Executive Officer until Pascal Soriot joins.","outcome":"checked"},"wikidata":"Q731938","precision":10,"second_source":{"on":"2026-11-08","url":"https://www.sec.gov/Archives/edgar/data/0000901832/000095010312004497/dp32579_6k.htm","note":"AstraZeneca's 2012 filing announces Soriot's appointment as CEO, with his duties and Board seat starting 1 October 2012.","tier":"primary","outcome":"added"}},"valid_from":"2012-10-01","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"AstraZeneca ceo: Pascal Soriot\", as of 2012-10-01. Claim clm_5E921CD2E098, https://asof.is/claim/clm_5E921CD2E098, accessed 2026-11-09. Source: https://www.astrazeneca.com/our-company/leadership.html.","url":"https://asof.is/claim/clm_5E921CD2E098","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"supersedes":[],"first_seen_at":"2026-11-08T15:21:53.607953+00:00","updated_at":"2026-11-09T10:06:39.25927+00:00","sources":[{"url":"https://www.astrazeneca.com/our-company/leadership.html","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/0000901832/000095010312004497/dp32579_6k.htm","tier":"primary","publisher":"sec.gov","published_at":null},{"url":"https://www.wikidata.org/wiki/Q731938","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"Pascal Soriot will take on his new responsibilities and join the AstraZeneca PLC Board as an Executive Director on 1 October 2012. Simon Lowth will remain as AstraZeneca’s Interim Chief Executive Officer until Pascal Soriot joins.","url":"https://www.sec.gov/Archives/edgar/data/0000901832/000095010312004497/dp32579_6k.htm"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"page-read":"its source page states the value and the date"}}}